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ABSTRACT  Monoclonal  antibodies  directed  against seven different  sites on  Dictyostelium 
myosin  (Peltz, G., J. A.  Spudich,  and  P.  Parham, 1985, J.  Cell  Biol.,  100: 1016-1023)  were 
tested for their ability to inhibit movement of myosin in vitro, using the Nitella-based  myosin- 
mediated  bead movement  assay (Sheetz, M. P.,  R. Chasan, and J. A. Spudich,  1984, J.  Cell 
Biol.,  99:  1867-1871).  To complement this functional  assay, we located the  binding  sites of 
these antibodies by electron microscopy, using the rotary shadowing technique.  One antibody 
bound  to  the  18,000-dalton  light  chain  and  inhibited  movement  completely.  All  of  the 
remaining antibodies bound to various positions along the rod portion of the myosin molecule, 
which is ~1,800 A long. Antibodies  that bound  to the rod about 470, 680, and  1400 A from 
the head-tail junction did  not alter myosin movement.  One antibody appeared to bind very 
close to the head-tail junction and to inhibit  movement  50%. Surprisingly, three  antibodies 
that bound about  1,200 A from  the head-tail junction  inhibited  movement  completely.  This 
inhibition did not depend  on using intact IgG, since Fab' fragments had the same effect. 
The interaction of myosin and  actin  is  fundamental for a 
wide  variety of cellular movements (17).  The  function  of 
myosin has been best studied in muscle where development 
of tension or speed of shortening can be measured to probe 
the effects of varying conditions on contraction of myofibrils. 
Myosin movement has not been measured in nonmuscle cells. 
However, the direct visualization of movement of myosin- 
coated beads along polar arrays of actin filaments from the 
alga Nitella (33) has provided a quantitative assay for myosin 
movement in vitro (32). We report here studies in which we 
have used this assay to assess the effects on movement of 
binding monoclonal antibodies to different probe sites on the 
myosin molecule. 
Anti-myosin  monocional  antibodies  provide  valuable 
probes  for regions  of the  myosin  molecule  important  for 
motility. Antibodies  specific for particular  muscle  myosin 
isozymes provide  important  tools  for  examination  of the 
distribution of myosin isozymes during development and in 
adult fibers. During early development muscle fibers destined 
to become either fast  or slow twitch fibers both react with 
antibodies directed against slow muscle myosin and fast mus- 
cle myosin (16).  These findings have been extended using 
monoclonal antibodies specific for adult myosin to show that 
structural changes occur in widely separated regions of the 
myosin molecule during myogenesis (4,  38).  Immunocyto- 
chemistry using polyclonal antibodies has been used to iden- 
tify individual fiber types and demonstrate the presence of 
more than one isozyme of myosin in a single muscle (14,  15). 
Nonmuscle myosins have been  localized in  the  contractile 
ring and in stress  fibers using immunofluorescence micros- 
copy (30, 37). Further studies that used myosin-specific anti- 
bodies have probed the correlation between the structure and 
function of the myosin molecule. Polycional antibodies spe- 
cific for the regulatory light chains or the essential light chains 
of scallop myosin abolished calcium regulation in myofibrils 
and myosin by elevating the actin-activated ATPase activity 
in the absence of calcium (36). These antibodies were then 
used to localize the light chains on the myosin heads using 
electron microscopy. Fab'  fragments specific for the regula- 
tory light chains and Fab' fragments specific for the essential 
light chains bind preferentially to scallop myosin in the nar- 
row region of the myosin head near its junction with the tail 
(13). A monoclonal antibody specific for the LC2 light chain 
of fast skeletal muscle myosin has been mapped by electron 
microscopy on the  myosin  head at the  head-rod junction; 
binding of this antibody to LC2 light chain does not affect 
the enzymatic activity of skeletal muscle myosin (38). Mono- 
clonal antibodies specific for several  epitopes in the 25-kilo- 
dalton and 50-kilodalton tryptic fragments of  the myosin head 
(S l) have been mapped (39). Monoclonal antibodies specific 
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structure and function of myosin in nonmuscle cells. Binding 
sites  of  several  antibodies  directed  against  Dictyostelium 
myosin (D. myosin)  ~  have been localized by Claviez et al. (7), 
but the effect of these antibodies on myosin function has not 
been reported as yet. Kiehart and Pollard (23) mapped binding 
sites of antibodies specific for Acanthamoeba myosin II and 
made  the  interesting  finding  that  a  monoclonal  antibody 
specific for the tail inhibits myosin ATPase activity by fila- 
ment disassembly. 
As described  in  the  previous paper by  Peltz  et  al.  (29), 
antibodies specific for seven distinct  sites on Dictyostelium 
myosin have been prepared. Ten monoclonal antibodies were 
isolated and designated Myl  to Myl0. The affinity of those 
antibodies  for  chymotryptic  fragments  of  Dictyostelium 
myosin divided  the  antibodies  into  two groups:  those  that 
bind to the tail portion of the molecule and those that bind 
to the  head  portion.  Localization at higher  resolution  was 
essential to interpret the effects of the antibodies on move- 
ment.  We  therefore  report  here  a  quantitative  analysis of 
binding sites using rotary shadowing and electron microscopy. 
These structural studies have been correlated with the effects 
of these antibodies on the rate of myosin movement in the 
functional in vitro assay described by Sheetz et al. (32). 
MATERIALS  AND  METHODS 
Proteins Used in This Study:  RNA-free  myosin was purified from 
Dictyostelium as described (26) with minor modifications (Griffith, L  G., and 
J. A. Spudich. manuscript in preparation). Ten monoc!onal anti-Dictyostelium 
myosin IgG antibodies, referred to as My I to My l 0 (or My 1  - 10), were prepared 
as described in the previous paper by Peltz et al. (29). The Fab' fragments of 
these antibodies were prepared  by pepsin digestion as described by Parham 
(27). 
Preparation of Beads Coated with  Dictyostelium  Myosin: 
Purified Dictyoste/ium myosin was attached to fluorescent beads (Covaspheres 
0.98 um diameter) (Covalent Technologies, Inc., Ann Arbor, MI). 1 vol of the 
stock  solution  of beads  was diluted  1:9  into  a  solution containing 5  mM 
potassium phosphate (pH 6.5), 0.2 mM dithiothreitol, 50 mM KCI and myosin 
at a  concentration of 0.2-0.4  mg/ml at 0*C for at least 2  h.  The beads were 
then  pelleted using a  microfuge  and  resuspended  in  1  vol  of assay buffer 
containing 5  mM  Tris (pH  7.5), 0.2 mM dithiothreitol, 20 mM  KCI, 2  mM 
EDTA, and 5% normal rabbit serum. 
Control beads were prepared by diluting 1 vol of stock solution of beads 
with 9 vol of assay buffer at 0*C for at least 2 h. After centrifugation, the beads 
were resuspended in I vol of assay buffer. 
Radioimmunoassay (RIA) for Binding of Anti-myosin Anti- 
bodies to Myosin-coated Beads:  Monoclonal  anti-myosin IgO was 
added to 20 ul of a  myosin-coated bead suspension to a concentration of 0.5 
mg/ml. After 2-4 h of incubation at 0*C, the beads were washed twice with 1 
ml of assay buffer. The pelleted beads were resuspended in 50 ~1 of assay buffer 
containing 500,000 cpm of ~251-1abeled F(ab')2 rabbit anti-mouse IgG (RAM). 
After I-2 h of incubation at 22°C, the beads were again washed twice using 1 
ml of assay buffer,  The amount of radioactivity bound to the pelleted beads 
was then measured. Experiments measuring the binding of Fab' fragments to 
myosin-coated beads were performed  in the  same manner except Fab'  was 
added to the myosin-coated bead solution to a concentration of 0.25  mg/ml. 
In  each  experiment,  nonspecific binding was  measured  as  the  amount  of 
radioactivity bound when a nonspecific control IgG ofisotype 3', was added to 
the myosin-coated bead suspension. As an additional control, the amount of 
radioactivity bound when beads lacking myosin were incubated with each of 
the monoclonal IgG antibodies or Fab' fragments was measured. 
Measurement of the Rate of Movement of Myosin-coated 
Beads  In  Vitro:  Monoclonal igG was added to suspensions  of myosin- 
coated beads to a concentration of 0.5 mg/ml. After a  3-h incubation at 4°C, 
the IgG-bead solutions were diluted 1:3 in 50 mM Tris, 25 mM KCI, 4  mM 
MgCl2, 4  mM  EGTA, 0.2 M  sucrose, 0.8% polyethylene glycol, l  mM  ATP 
(pH  7.6),  and then were pipetted onto the cytoplasmic surface of a dissected 
J  Abbreviations  used  in  this  paper:  D.  myosin,  Dictyostelium 
myosin; RAM, rabbit anti-mouse IgG; RIA, radioimmunoassay. 
Nitetla cell according to procedures described by Sheetz, Chasan, and Spudich 
(32).  The dissected Nitella cell was immersed in 5 mM imidazole, 25 mM KCI, 
4  mM  MgCIz,  4  mM  EGTA,  1 mM ATP (pH  7.0) containing 100 ug/ml of 
monoclonal  lgG.  The  beads  settled  on  the  rows  of actin  cables and  their 
movement was monitored with a water-immersible 40x objective (Carl Zeiss, 
Inc.,  Thornwood,  NY)  for  10-30  min.  All  observations were  recorded  on 
videotape for analysis. Measurement of the effect of Fab' fragments on the rate 
of bead movement was performed by the same procedure, except Fab'  was 
added to the myosin-coated bead solution to a concentration of 0.25 mg/ml. 
The rate of bead movement was determined by following each of 10-50 
distinct beads or bead aggregates over a distance of 40/~m. The maximum rate 
of migration of each particle measured over at least a  10-urn distance was used 
as the velocity of movement. 
Incubation  of Myosin with Antibodies  and Rotary Shad- 
owing:  Typically, 0.03 mg of myosin (stored at 0.8-2 mg/ml) was incubated 
with lgG or Fab' at a  1:1 molar ratio in 0.5 M  KC1, 10 mM Tris (PH 7.5), 2 
mM EDTA,  1 mM dithiothreitol, and 0.02% azide at 22"C for 0.5 h. In some 
cases, myosin plus IgG was incubated at 4"C for  1-3 h. The antibodies were 
stored at -20"C in 5 mM Tris (pH 7.5),  50 mM NaCI, and 0.02% azide. Before 
incubation with myosin, a small aliquot was thawed and spun in a  Beckman 
airfuge (Beckman Instruments, Inc., Palo Alto, CA) for 10 min at 30 pounds 
per square inch (psi) to remove aggregates. The concentration was determined 
spectroscopically (~  =  15), 
Samples were diluted to  10-20 ;zg/ml myosin in 70% glycerol and 0.3 M 
ammonium acetate (1  mM  dithiothreitol and  I  mM  EDTA were present in 
some  experiments) and  immediately sprayed  onto  freshly cleaved mica as 
described  by  Tyler and  Branton  (35).  Samples were  mounted  on  a  rotary 
platform in an Edwards evaporator (Edwards High Vacuum, Inc., Grand Island, 
NY) and dried in vacuo. A 6* shadow angle was used for rotary shadowing with 
platinum (0.008  inch wire, 3 cm) vaporized from a  heated tungsten filament 
(13). The resulting replicas were coated with a supporting film of carbon, floated 
on distilled water, and picked up on bare 400-mesh grids. Micrographs were 
recorded with a Philips EM201 (Philips Electronic Instruments, Inc., Mahwah, 
N J) operating at 80 kV accelerating voltage. The magnification was calibrated 
using  negatively stained  tropomyosin  paracrystals (395  A  periodicity) (8). 
Antibody binding sites were estimated by measurement on enlarged images 
(x~2.6) using a digital data tablet connected to a microcomputer. 
RESULTS 
Monoclonal Anti-myosin Antibodies  Bind to 
Myosin  Immobilized on Beads 
Anti-myosin antibody binding to myosin-coated beads was 
measured for each of the IgG monoclonal antibodies. They 
all showed substantial binding above control levels (Table I). 
TABLE  I 
Binding of Monoclonal IgG and Fab' Fragments to Myosin- 
coated Beads 
.Radioactivity bound (cpm) 











1,300  3,500 
2,200  13,300 
5,4O0  41,800 
1,200  31,000 
2,000  25,900 
1,400  22,2O0 
1,500  21,300 
3,100  20,900 
2,900  14,000 
600  18,000 
Fab' 
My1  400  12,600 
My6  1,000  20,800 
My8  1,800  5,600 
My10  1,400  18,800 
The amount of '2SI-RAM bound to control  or myosin-coated beads after 
incubation With monoclonal IgG or Fab' fragments was determined as de- 
scribed in Materials  and Methods. 
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measured. Fab' fragments of My l, My6, and My l0 showed 
substantial binding, whereas the Fab' fragment of  My8 bound 
very weakly to myosin-coated beads. 
Some of the Monoclonal Anti-myosin Antibodies 
Inhibit the Rate of Movement of 
Myosin-coated Beads 
Beads coated with D.  myosin moved along Nitella actin 
cables with a velocity of about 1 ~m/s (Fig.  1, Table II). The 
presence of a nonspecific control IgG did not alter this rate. 
My8, which binds to the 18-kD light chain of D. myosin (29), 
completely inhibited bead movement. Monoclonal antibodies 
directed against four different sites in the tail portion of D. 
myosin (My2, My3, My4, and My9) did not affect the rate of 
bead movement. However, four of  the monoclonal antibodies 
known to bind to the myosin heavy chain (29) did inhibit 
myosin-bead movement. My6, which appears to bind to the 
rod portion of the myosin heavy chain very near the head-tail 
junction (see below), inhibited the rate of bead movement by 
50%. Myl, My5, and Myl0, which bind to a spatially related 
site in the tail portion of the heavy chain of myosin (29), 
completely inhibited bead motility. 
To minimize possible steric blocking due to the size of an 
intact IgG molecule, we assayed the effects of Fab' fragments 
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FIGURE  1  Histogram  of  the  velocity of  D.  myosin-coated  bead 
movement along Nitella  actin cables measured in the presence of 
several  representative  antibodies.  After  incubation  of  myosin- 
coated beads with the indicated IgG at a concentration of 0.5 mg/ 
ml, the rate of bead movement along the actin cables of Nitella  in 
the presence of the indicated IgG at a concentration of 100 ~g/ml 
was measured as described in Materials and Methods. 
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TABLE  II 
Effect of Monoclonal Antibodies  on Rate of Movement of 
Myosin-coated  Beads 
Number of 
IgG  beads  Velocity (p,  mls) 
none  24  1.0 ±  0.2 
Control IgG  42  1.0 _+ 0.3 
My1  25  0 
My2  27  1.0 ±  0.2 
My3  20  1.1  +  0.2 
My4  22  1.1  ±  0.3 
My5  25  0 
My6  25  0.5 ±  0.1 
My8  25  0 
My9  21  1.2 ±  0.2 
My10  25  0 
Fab' 
My1  25  0 
My6  12  0.8 +  0.2 
My8  11  0.6 _-_ 0.2 
My10  25  0 
Velocity of Dictyostelium myosin-coated bead movement along Nitella actin 
cables in the presence of monoclonal anti-myosin IgG or  Fab' fragments. 
The rate of bead movement was measured as described in  Materials and 
Methods. 
My1  and My10 completely inhibited bead movement. The 
Fab' fragment of MyS, which was shown to bind weakly to 
myosin-coated beads,  partially  inhibited  the  rate  of bead 
movement, and no inhibition was  observed with the Fab' 
fragment of My6. 
The Antibody Binding Sites were Localized by 
Electron Microscopy 
D. myosin molecules have the characteristic shape exhibited 
by myosin from a number of muscle and nonmuscle sources 
(Fig.  2)  (12).  Images  of myosin  molecules contrasted  for 
electron microscopy by rotary shadowing showed two pear- 
shaped heads attached to a long narrow tail.  The tail of D. 
myosin (1,800 A; Fig.  2) (7) is ~250 A  longer than that of 
muscle myosin (1,560 A) (11). IgG or Fab' fragments can be 
distinguished, in general, from the myosin molecule itself in 
replicas of antibody-myosin complexes (7, 13, 38), and bind- 
ing of Myl-10 to D. myosin was examined by this method. 
The binding sites of six antibodies have been localized using 
this approach. Examples of myosin molecules with three of 
the antibodies which do not affect movement are shown in 
Fig. 2. My3 binds 470 A from the heads, about one-fourth of 
the total tail length from the head-tail junction. My2 binds 
~680 ,~ distal from the heads, and My4 binds about three- 
fourths of the tail length (1,350/~) from the heads. 
The binding site of My 10, one of the antibodies specific for 
the tail which inhibits movement, is demonstrated in Fig. 3. 
Both intact IgG and Fab' fragments were clearly seen bound 
to the myosin tail about  1,200/~, or two-thirds of the total 
tail length, from the head-tail junction. Examination of fields 
of myosin plus Myl0 antibodies revealed that this antibody 
only binds at one position along the tail;  no examples with 
the My l0 antibody bound elsewhere along the myosin mole- 
cule were seen. Myl and My5 antibodies also bound ~ 1,200 
from the head-tail junction (data not shown). These findings FIGURE  2  Rotary-shadowed D.  myosin  molecules 
with bound IgG showing binding sites of antibodies 
which do not affect motility. Myosin molecules with- 
out bound antibody  (row  1), with antibody-bound 
My3 (row 2), with antibody-bound  My2 (row 3), or 
with antibody-bound  My4 (row 4). x125,000. 
FIGURE  3  D.  myosin molecules with bound  My10, 
an  antibody  which  inhibits  movement.  (Top  row) 
Myosin  molecules  with  My10  IgG; (bottom  row) 
myosin molecules with My10 Fab'. x125,000. 
agree  with  blocking experiments which suggested that these  tail were made on 30-50 examples of each antibody mapped. 
antibodies,  Myl,  My5  and  Myl0,  bind  to spatially  related  These results are summarized in Fig. 4. Each antibody bound 
sites (29).  to a distinct narrowly defined site on the myosin tail, and no 
Measurements of the location of the antibodies along the  binding to  other  sites  on  the  molecule was  observed.  The 
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by the size of the IgG. 
In any given field of molecules, not all myosin molecules 
clearly exhibited bound antibody.  Some myosin molecules 
had no antibody bound.  Aggregates  of myosin cross-linked 
by antibody were often seen. The percentage of myosin mol- 
ecules with bound antibody is shown in Table III.  Three of 
the  monoclonal antibodies,  My7,  My8  and  My9,  did  not 
show any binding to myosin in the electron microscope. Two 
of these antibodies, My7 and My8, have been shown to have 
lower affinity than the other anti-myosin antibodies by solid- 
phase RIA (29).  Although the frequency of molecules with 
bound My6 was low, this antibody consistently appeared close 
to or at the junction of the head with the tail (Fig. 5). 
In light  of the apparent low affinity of the My6 antibody 
for myosin under the conditions used for rotary shadowing, 
supportive evidence for the localization of the My6 antibody 
binding  site  was  provided  by  examination  of the  soluble 
fragment generated from D. myosin by chymotrypsin cleavage 
(28). This fragment, which is soluble at low ionic strength and 
retains ATPase activity, binds My6 (29). Images of the soluble 
fragment prepared by rotary shadowing revealed that it was 
heterogenous (Fig.  5). Many fragments appeared to be com- 
prised of two heads and a short tail,  similar to heavy mero- 
myosin from skeletal  muscle myosin but having less of the 
My 4 SITE 
10 
My 2 SITE 
,  i 
=E  l  My 1,5,10 SITE  END OF | 
2°F  I  TA'L1 
My 3 SITE 
5 
0 
0  400  800  1200  1600  2000 
DISTANCE  FROM  HEAD-TAIL JUNCTION (~) 
FtGURE 4  Histogram  showing the  positions  of antibody binding 
sites along the myosin tail. The distance from the head-tail junction 
to the center of the antibody on the tail and the total length of the 
tail were measured. The position of the antibody binding site was 
then normalized with an average tail length of 1800 ,~ (from meas- 
urements of myosin molecules with no antibody bound). 
TABLE  III 
Extent of Antibody Binding to Myosin by Electron Microscopy 
Percent of 
Number of myosin  myosin with 
Antibody  molecules scored  bound antibody 
My2  850  43 
My3  850  47 
My4  785  68 
My10  1,015  41 
My10 Fab'  290  35 
Myl  125  44 
My1Fab'  75  28 
My5  185  48 
Percentage  of  myosin  molecules  with  bound  antibody.  The  number  of 
molecules which were unclear (10-20% of total molecules counted), because 
they lacked  some characteristic  feature of myosin,  were poorly contrasted, 
or were aggregated, was subtracted before the calculation of percentages. 
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FIGURE 5  Dictyostelium-soluble fragment  and  two  examples  of 
myosin molecules with My6 IgG bound. (Top) My6 IgG appears to 
bind to  myosin  at or near the head-tail  junction.  My6 binding is 
rarely  seen; only ~10% of the  myosin  molecules exhibit bound 
My6. x125,000. (Bottom) My6 is known to bind to the Dictyoste- 
lium-soluble fragment (29). Many molecules of the soluble fragment 
are comprised of two heads and a short  tail,  which is consistent 
with  the  binding site  suggested by  the examples shown above. 
Estimates of the number of fragments exhibiting  two heads attached 
to a short  tail suggests at least half of the cleavages produce this 
fragment, x 100,000. 
rod portion of the molecule. Individual heads and short rod 
fragments were also  seen.  In general, the appearance of the 
soluble fragment preparation is consistent with the apparent 
binding site of My6 on myosin (Fig.  5, top), i.e. close to the 
junction of the rod with the tail. 
DISCUSSION 
These studies begin to provide a map of regions of the myosin 
molecule important for movement per se. Our preliminary 
map,  presented in  Fig.  6,  shows  the  location  of antibody 
binding sites along the myosin tail and the rate of movement 
of myosin-coated beads in the presence of each antibody. The 
sites important for motility shown here lie at widely different 
sites on the molecule. 
One site required for motility, identified by My8, is on the 
18-kD light chain. This light chain appears analogous to the 
regulatory light chains found in  smooth  muscle and  other 
nonmuscle myosins (see reference 2 for review). Phosphoryla- 
tion of these light chains regulates the actin-activated ATPase 
activity (1,  3, 6,  10) and assembly state of the myosin (31). 
The D. myosin  18-kD light chain is phosphorylated in vivo 
during growth of  the amoebae (24), suggesting that light chain FIGURE 6  Diagram of a D. myosin molecule showing the location 
of antibody binding sites. The binding sites for My8 and My6 are 
tentative. Shown below each antibody binding site is the velocity 
of myosin-coated beads in the presence of that antibody. 
phosphorylation also is involved in regulating myosin activity 
in Dictyostelium.  Although the location of this  18-kD light 
chain was not directly visualized by electron microscopy, it 
can  be  inferred  from  the  position  of the  binding  sites  of 
antibodies specific for regulatory light chains of other myosins. 
Polyclonal antibodies specific for scallop myosin regulatory 
light chains (13) and monoclonal antibodies specific for ver- 
tebrate  skeletal  myosin  LC2  light  chains  (38)  bind  to  the 
narrow "neck" portion of the myosin head near its junction 
with the tail. 
The mechanism for regulation  requiring phosphorylation 
of light chains may involve changes in the conformation or 
position  of the  light chain  and  its contacts with the  heavy 
chain.  Cross-linking experiments have shown that the  regu- 
latory light chain in scallop myosin, a regulated myosin that 
binds calcium directly,  moves relative to the essential light 
chain upon activation (18). My8 binding to the Dictyostelium 
18-kD  light  chain  may block  some  analogous  movement. 
My8 IgG could also inhibit myosin motility by intramolecule 
cross-linking of myosin  heads.  Alternatively,  My8  binding 
may stabilize or enhance formation of a folded myosin con- 
formation (discussed below) which is unable to act in  force 
generation.  The lack of complete inhibition  of bead move- 
ment by the Fab' fragment of My8 is probably due to its low 
affinity for binding to myosin. 
Another site required for motility is defined by the binding 
of My6.  This antibody binds to the  soluble fragment of D. 
myosin (29),  and  images of myosin  molecules with  bound 
My6  antibody suggest that  this  antibody binds  on  the  rod 
near the junction of the heads with the tail. This region of the 
myosin molecule near the head-tail junction may be involved 
in  movements of the head relative to the tail important for 
motility. Myosin heads are thought to change their angle of 
attachment to actin in the course of the crossbridge cycle (5, 
21,  22).  Such  changes may be restricted  in  the  presence of 
My6. 
The third interesting region that is revealed by these studies 
is on the myosin rod approximately two-thirds of the distance 
from the head-tail junction to the tip of the tail. Cross-linking 
of molecules by bivalent intact antibody cannot explain in- 
hibition of myosin movement by My l, My5, and My 10 since 
Fab' fragments of Myl and Myl0 also inhibit the movement. 
One  intriguing  possibility is  that  this  region  is  critical  for 
motive force  production  by  some  mechanism  such  as  the 
helix-coil transition proposed by Harrington (19, 20). Another 
possible explanation, based on recent studies of  other myosins, 
is  that  this  region  of the  myosin tail  might fold back and 
physically  interact  with  the  head  region  of the  molecule. 
Smooth muscle myosin and thymus myosin assume such a 
folded "hair-pin" structure under certain conditions (9, 34). 
There are several binding sites in the D. myosin tail that do 
not appear to be important for myosin movement. However, 
one of these sites, specified by My4, does appear to be impor- 
tant for myosin filament formation. In the presence of My4, 
myosin filament formation is inhibited (29). The region iden- 
tified by My4 is located about three-fourths of the total tail 
length from the junction of the heads with the tail. The My4 
binding site is only ~150 .A away from the Myl, My5, Myl0 
binding site.  It is therefore remarkable that these antibodies 
have such different effects on the myosin function. The mono- 
clonal  antibodies  provide  the  ability  to  resolve  particular 
functional regions within the tail. 
To  further understand  the  effects of these  antibodies  on 
myosin motility in  the bead assay, we must determine the 
arrangement of myosin on the beads. It will be important, for 
example, to  assess whether thick  filament formation is  re- 
quired.  The low ionic strength  of the  myosin-bead mixture 
would favor thick filament formation, but adherence to the 
bead surface may disrupt filaments or inhibit their formation. 
Indeed,  Myl,  My4,  My5,  and  Myl0  are  all  incapable  of 
binding  to  myosin  filaments in  solution  (29)  and  yet they 
bind to myosin on beads and, except for My4, inhibit bead 
movement. This suggests that the myosin responsible for bead 
movement may not be in a filamentous form. Future studies 
directed at a better definition of the topology of the myosin- 
coated bead surface are necessary. 
These  studies  represent  the  first  attempts  to  define  the 
portions  of the  myosin  molecule  critical  for  its  ability  to 
move.  These  findings  are  being  extended  using  other  ap- 
proaches to modify the myosin molecule, such as proteolytic 
fragmentation. Assays of the ability of myosin fragments or 
other modified myosins to move will further define the por- 
tions  of the  myosin  molecule  involved  in  generating  the 
motive force. 
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